Abstract
Three models for the relationship between scientific research and practical intervention (as in technology development or medical therapy) are presented. The cascade model proceeds on the assumption that the control of natural processes requires the disentangling of their underlying causal relations. Emergentism claims that intervention needs to take subtle features of experience into account whose diversity and wealth transcend the grip of fundamental principles. Practical challenges need to be addressed by jettisoning the principles and by turning to the particulars of experience instead. The interactive view grants that general theory fails to capture the phenomena to a degree necessary to direct targeted intervention and claims that the empirical details only serve to complete and correct a theory-based conceptual framework. Studying cases from cancer research buttresses the interactive view. A theoretical framework for understanding the disease is of critical importance for devising treatment options. But these options are only vaguely outlined and need to be spelled out by drawing on the particulars of experience.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adam, M. 2005. Integrating research and development: The emergence of rational drug design in the pharmaceutical industry. Studies in History and Philosophy of Biological and Biomedical Sciences 36:513–537.
Adam, M., M. Carrier, and T. Wilholt. 2006. How to serve the customer and still be truthful: Methodological characteristics of applied research. Science and Public Policy 33:435–444.
Bacon, F. 1620. The New Organon (trans. J. Spedding, R.L Ellis, and D.D. Heath), The Works VIII. Boston: Taggard and Thompson, 1863.
Balkwill, F., K.A. Charles, and A. Mantovani. 2005. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7:211–217.
Balkwill, F., and A. Mantovani. 2001. Inflammation and cancer: Back to Virchow? The Lancet 357:539–545.
Bod, R. 2006. Towards a general model of applying science. International Studies in the Philosophy of Science 20:5–25.
Carrier, M. 2004. Knowledge gain and practical use: Models in pure and applied research. In Laws and Models in Science, ed. D. Gillies, 1–17. London: King’s College Publications.
Carrier, M. 2009. Theories for use: On the bearing of basic science on practical problems. In EPSA Epistemology and Methodology of Science: Launch of the European Philosophy of Science Association, ed. M. Suárez, et al., 23–34. Dordrecht: Springer.
Carrier, M. 2010. Research under pressure: Methodological features of commercialized science. In The Commodification of Academic Research: Analyses, Assessments, Alternatives, ed. H. Radder, 158–186 Pittsburgh, PA: Pittsburgh University Press.
Cartwright, N. 1983. How the Laws of Physics Lie. Oxford: Clarendon Press.
Cartwright, N. 1994 [1996]. Fundamentalism versus the patchwork of laws. In The Philosophy of Science, ed. D. Papineau, 314–326. Oxford: Oxford University Press.
Cartwright, N. 1997. Models: The blueprints for laws. PSA 1996 II. Supplement to Philosophy of Science 64:S292–S303.
Cartwright, N. 1998. How theories relate: Takeovers or partnerships? Philosophia Naturalis 35:23–34.
Chang, J.C., E.C. Wooten, A. Tsimelzon, S.G. Hilsenbeck, M.C. Gutierrez, R. Elledge, S. Mohsin, C.K. Osborne, G.C. Chamness, D.C. Allred, and P. O’Connell. 2003. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. The Lancet 362:362–369.
Coussens, L.M., and Z. Werb. 2002. Inflammation and cancer. Nature 420:860–866.
Descartes, R. 1637 [1960]. Discours de la méthode. Hamburg: Meiner.
Dvorak, H.E. 1986. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. The New England Journal of Medicine 315:1650–1659.
Finzer, P., A. Aguilar-Lemarroy, and F. Rosl. 2002. The role of human Papillomavirus Oncoproteins E6 and E7 in apoptosis. Cancer Letters 188:15–24.
Finzer, P., A. Krueger, M. Stöhr, D. Brenner, U. Soto, C. Kuntzen, P.H. Krammer, and F. Rösl. 2004. HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F-p73 pathway. Oncogene 23(28):4807–4817.
Giardiello, F.M., S.R. Hamilton, A.J. Krush, S. Piantadosi, L.M. Hylind, P. Celano, S.V. Booker, C.R. Robinson, and G.J. Offerhaus. 1993. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. The New England Journal of Medicine 328:1313–1316.
Godin, B.. 2006. The linear model of innovation: The historical construction of an analytical framework. Science, Technology and Human Values 31:639–667.
Gupta, R.A., and R.N. DuBois. 2001. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nature Reviews Cancer 1:11–21.
Hanahan, D., and R.A. Weinberg. 2000. The Hallmarks of cancer. Cell 100:57–70.
Labayle, D., D. Fischer, P. Vielh, F. Drouhin, A. Pariente, C. Bories, O. Duhamel, M. Trousset, and P. Attali. 1991. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101:635–639.
Liu, Y., and W.F. Bodmer. 2006. Analysis of p53 mutations and their expression in 56 colorectal cancer cell lines. Proceedings of the National Academy of Sciences 103(4):976–981.
Lotze, M.T. 2004. Inflammation, necrosis, and cancer. In Cancer and Inflammation, eds. D.W. Morgan, et al., 189–196. Basel: Birkhäuser.
Lotze, M.T., and R.B. Herberman. 2004. Cancer as a chronic inflammatory disease: Role of immunotherapy. In Cancer and Inflammation, eds. D.W. Morgan, et al., 21–51. Basel: Birkhäuser.
Lozano, A.M., and S.K. Kalia. 2005. New movement in Parkinson’s. Scientific American 293(1):68–75.
Morrison, M. 1999. Models as autonomous agents. In Models as Mediators. Perspectives on Natural and Social Sciences, eds. M. Morgan, and M. Morrison, 38–65. Cambridge: Cambridge University Press.
Mueller, M.M., and N.E. Fusenig. 2004. Friends or foes – Bipolar effects of the tumour stroma in cancer. Nature Reviews Cancer 4:839–849.
Nam, J.H., and S. Murthy. 2004. Chronic inflammation and cancer in various organ systems. In Cancer and Inflammation, eds. D.W. Morgan , et al., 1–20. Basel: Birkhäuser.
Palma, M., E. Ristori, E. Ricevuto, G. Giannini, and A. Gulino. 2006. BRCA1 and BRCA2: The genetic testing and the current management options for mutation carriers. Critical Reviews in Oncology/Hematology 57(1):1–23.
Parsonnet, J. 1999. Introduction. In Microbes and Malignancy, ed. J. Parsonnet, 3–15. New York, NY: Oxford University Press.
Rosenberg, N. 1991. Critical issues in science policy research. Science and Public Policy 18:335–346.
Sauer, A. 2004. Im Wandel der Gezeiten. Spektrum der Wissenschaft 05/2004:56–59.
Shacter, E.Y., and S.A. Weitzman. 2002. Chronic inflammation and cancer. Oncology 16:217–231.
Stokes, D.E. 1997. Pasteur’s Quadrant. Basic Science and Technological Innovation. Washington, DC: Brookings Institution Press.
Thun, M.J., S.J. Henley, and C. Patrono. 2002. Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues. Journal of the National Cancer Institute 94:252–266.
Toellner, R. 2002. Im Hain des Akademos auf die Natur wißbegierig sein: Vier Ärzte der Freien Reichsstadt Schweinfurt gründen die Academia Naturae Curiosum. In 350 Jahre Leopoldina – Anspruch und Wirklichkeit, eds. B. Parthier , and D. von Engelhardt, 14–43. Halle: Deutsche Akademie der Naturforscher Leopoldina.
Van Staa, T.P., T. Card, R.F. Logan, and H.G. Leufkens. 2005. 5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: A large epidemiological study. Gut 54:1573–1578.
Velayos, F.S., J.P. Terdiman, and J.M. Walsh. 2005. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: A systematic review and meta analysis of observational studies. The American Journal of Gastroenterology 100:1345–1353.
Walker, D.R., J.P. Bond, R.E. Tarone, C.C. Harris, W. Makalowski, M.S. Boguski, and M.S. Greenblatt. 1999. Evolutionary conservation and somatic mutation hotspot maps of p53: Correlation with p53 protein structural and functional features. Oncogene 18(1):211–218.
Winsberg, E. 2003. Simulated experiments: Methodology for a virtual world. Philosophy of Science 70:105–125.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Carrier, M., Finzer, P. (2011). Theory and Therapy: On the Conceptual Structure of Models in Medical Research. In: Carrier, M., Nordmann, A. (eds) Science in the Context of Application. Boston Studies in the Philosophy of Science, vol 274. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9051-5_6
Download citation
DOI: https://doi.org/10.1007/978-90-481-9051-5_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9050-8
Online ISBN: 978-90-481-9051-5
eBook Packages: Humanities, Social Sciences and LawPhilosophy and Religion (R0)